Advanced Bionics Newswire

Advanced Bionics Newswire

Comprehensive Real-Time News Feed for Advanced Bionics.

Results 1 - 20 of 237 in Advanced Bionics

  1. Epicardial LAA Closure Device Consumption 2016 Market Overview and GrowthRead the original story

    Yesterday | Emailwire.com

    ReportsWeb.com has announced the addition of the 'Global Epicardial LAA Closure Device Consumption 2016 Market Research Report' focuses on major leading Consumption players, share, trends, opportunities and new investment projects. The Global Epicardial LAA Closure Device Market Consumption 2016 Research Report is a professional and in-depth study on the current state of the Epicardial LAA Closure Device market.

    Comment?

  2. Boston Scientific Corp. (BSX) Position Lowered by Metropolitan Life Insurance Co. NYRead the original story w/Photo

    Thursday Jul 21 | Daily Political

    Metropolitan Life Insurance Co. NY cut its stake in shares of Boston Scientific Corp. by 1.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission.

    Comment?

  3. Boston Scientific Corp. (BSX) Reaches New 12-Month High at $24.45Read the original story w/Photo

    Wednesday Jul 20 | Daily Political

    Boston Scientific Corp. reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $24.45 and last traded at $24.30, with a volume of 6,621,862 shares trading hands.

    Comment?

  4. Boston Scientific to settle tax case with IRS for $275MRead the original story w/Photo

    Wednesday Jul 20 | Seeking Alpha

    Boston Scientific is poised to ink a settlement agreement with the IRS related to a disputed tax liability related to transfer pricing issues for Guidant for the years 2001 - 2006 and BSX's tax years 2006 and 2007. If the settlement is finalized, BSX will pay $275M plus accrued interest.

    Comment?

  5. Boston Scientific Corp. (BSX) Upgraded at Zacks Investment ResearchRead the original story w/Photo

    Monday Jul 18 | Daily Political

    They currently have $26.00 price target on the stock. According to Zacks, "We remian optimistic about Boston Scientific's recently introduced global restructure plan, the execution of which will result in fulfillment of its margin leverage goals and help Boston Scientific produce low-to-mid-teens EPS growth, ahead of the industry average.

    Comment?

  6. Traders Sell Shares of Boston Scientific Corp.Read the original story w/Photo

    Saturday Jul 16 | Daily Political

    Traders sold shares of Boston Scientific Corp. on strength during trading on Thursday. $19.61 million flowed into the stock on the tick-up and $41.46 million flowed out of the stock on the tick-down, for a money net flow of $21.85 million out of the stock.

    Comment?

  7. Traders Sell Boston Scientific Corp.Read the original story w/Photo

    Friday Jul 15 | Daily Political

    Investors sold shares of Boston Scientific Corp. on strength during trading hours on Thursday. $19.61 million flowed into the stock on the tick-up and $41.46 million flowed out of the stock on the tick-down, for a money net flow of $21.85 million out of the stock.

    Comment?

  8. Boston Scientific Corp. (BSX) Reaches New 1-Year High at $23.99Read the original story w/Photo

    Thursday Jul 14 | Daily Political

    Shares of Boston Scientific Corp. reached a new 52-week high during trading on Tuesday . The stock traded as high as $23.99 and last traded at $23.69, with a volume of 4,840,501 shares traded.

    Comment?

  9. Boston Scientific Corp. (BSX) Shares Sold by Canada Pension Plan Investment BoardRead the original story w/Photo

    Wednesday Jul 13 | Daily Political

    Canada Pension Plan Investment Board cut its position in shares of Boston Scientific Corp. by 90.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,060 shares of the company's stock after selling 938,000 shares during the period.

    Comment?

  10. Boston Scientific Corp. (BSX) Upgraded to "Buy" by Zacks Investment ResearchRead the original story w/Photo

    Wednesday Jul 13 | AmericanBankingNews.com

    The firm presently has a $26.00 price target on the stock. Zacks Investment Research's target price suggests a potential upside of 10.03% from the stock's current price.

    Comment?

  11. Zacks Investment Research Upgrades Boston Scientific Corp. (BSX) to "Buy"Read the original story w/Photo

    Wednesday Jul 13 | AmericanBankingNews.com

    The brokerage currently has a $26.00 price target on the stock. Zacks Investment Research's price objective indicates a potential upside of 9.98% from the stock's current price.

    Comment?

  12. Boston Scientific Corp. (BSX) Downgraded by Zacks Investment Research to "Hold"Read the original story w/Photo

    Wednesday Jul 13 | Daily Political

    According to Zacks, "We remian optimistic about Boston Scientific's recently introduced global restructure plan, the execution of which will result in fulfillment of its margin leverage goals and help Boston Scientific produce low-to-mid-teens EPS growth, ahead of the industry average. Boston Scientific is currently leaving no stone unturned to strengthen its core businesses and invest in new technologies and global markets, which accounted for the sales upside across all its geographies in the first quarter.

    Comment?

  13. Boston Scientific Corp. (BSX) Downgraded by Zacks Investment ResearchRead the original story w/Photo

    Tuesday Jul 12 | AmericanBankingNews.com

    According to Zacks, "We remian optimistic about Boston Scientific's recently introduced global restructure plan, the execution of which will result in fulfillment of its margin leverage goals and help Boston Scientific produce low-to-mid-teens EPS growth, ahead of the industry average. Boston Scientific is currently leaving no stone unturned to strengthen its core businesses and invest in new technologies and global markets, which accounted for the sales upside across all its geographies in the first quarter.

    Comment?

  14. Boston Scientific Corp. (BSX) Lowered to "Hold" at Zacks Investment ResearchRead the original story w/Photo

    Tuesday Jul 12 | AmericanBankingNews.com

    According to Zacks, "We remian optimistic about Boston Scientific's recently introduced global restructure plan, the execution of which will result in fulfillment of its margin leverage goals and help Boston Scientific produce low-to-mid-teens EPS growth, ahead of the industry average. Boston Scientific is currently leaving no stone unturned to strengthen its core businesses and invest in new technologies and global markets, which accounted for the sales upside across all its geographies in the first quarter.

    Comment?

  15. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story w/Photo

    Tuesday Jul 12 | Business Wire

    Automotive ... World Cleaning Robot Market - Opportunities and Forecasts to 2022 - Key Players are Dyson, Samsung Electronics & Ecovacs Robotics - Research and Markets )--Research and Markets has announced the addition of the "World Cleaning Robot Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.

    Comment?

  16. Boston Scientific Corp. (BSX) Sets New 52-Week High at $23.61Read the original story w/Photo

    Friday Jul 8 | Daily Political

    Shares of Boston Scientific Corp. hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $23.61 and last traded at $23.59, with a volume of 6,331,355 shares traded.

    Comment?

  17. Belo Sun Mining Announces $75 Million Bought Deal FinancingRead the original story w/Photo

    Wednesday Jul 6 | Market Wire

    Belo Sun Mining Corp. has announced today that it has entered into an agreement with a syndicate of underwriters co-led by TD Securities Inc. and Canaccord Genuity, under which the underwriters have agreed to purchase on a bought deal basis by way of a short form prospectus, 77,320,000 common shares , at a price of $0.97 per Common Share for gross proceeds of approximately $75 million . The Company has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any.

    Comment?

  18. MediPoint: Renal Denervation - Global Analysis and Market Forecasts Report | ResearchmozRead the original story

    Wednesday Jul 6 | Emailwire.com

    Researchmoz added Most up-to-date research on "MediPoint: Renal Denervation - Global Analysis and Market Forecasts" to its huge collection of research reports. Renal denervation catheters are categorized into the following: radiofrequency catheters, ultrasound catheters, and micro-injection catheters.

    Comment?

  19. Boston Scientific Co. (NYSE:BSX) Receives Average Recommendation of "Buy" from AnalystsRead the original story w/Photo

    Tuesday Jun 28 | Daily Political

    Shares of Boston Scientific Co. have received a consensus recommendation of "Buy" from the twenty-six analysts that are covering the firm.

    Comment?

  20. Boston Scientific Co. (BSX) Stock Rating Reaffirmed by Piper JaffrayRead the original story w/Photo

    Thursday Jun 23 | Daily Political

    's stock had its "overweight" rating reiterated by investment analysts at Piper Jaffray in a report issued on Tuesday. They presently have a $26.00 price objective on the stock.

    Comment?